BloggingStocks has a new home! Daily Finance.

Click here to visit the new home of BloggingStocks!

Hot on DailyFinance:

See More Stories

Option update: POZEN option prices elevated on FDA marketing approval

Posted Apr 16th 2008 2:31PM by Paul FosterPaul Foster RSS Feed
Filed under: Options


POZEN Inc. (NASDAQ: POZN) recently up $3.62 to $14.15 in pre-open trading:


The FDA granted marketing approval for POZN's Treximet (treatment for migraines). Smith Barney increased its price target on POZN to $19. POZN over all option implied volatility of 130 was above its 26-week average of 89 according to Track Data, suggesting large price movement.

Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Tags: option implied volatility, OptionImpliedVolatility, POZEN

Print this

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+50.9012,852.13
NASDAQ+18.852,922.73
S&P 500+5.981,348.62

Last updated: February 13, 2012: 11:45 AM

Hot Stocks

General Electric

19.035+0.16(+0.85)

Alcoa

10.36+0.07(+0.68)

Apple Inc

499.60+6.18(+1.25)

Google Inc 'A'

612.285+6.375(+1.05)

Bank of America

8.265+0.195(+2.42)

Wal-Mart Stores

61.98+0.08(+0.13)

Exxon Mobil Corp

84.17+0.37(+0.44)

Ford

12.52+0.08(+0.64)

Citigroup

33.425+0.50(+1.52)

IBM

192.41-0.01(-0.01)

Yahoo

16.095-0.045(-0.28)

Starbucks

49.19+0.37(+0.76)

Microsoft

30.50+0.005(+0.02)

Home Depot

45.81+0.48(+1.06)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329151516449 ms.